5. BIOIMAGING RESEARCH GROUP<strong>Research</strong> StrategyThe group is involved in three main strands <strong>of</strong> <strong>research</strong>:i) nanotoxicologyii) tissue development, andiii) instrumentation.Nanotoxicology:The Group has been successful in attracting EU FP6 funding <strong>of</strong> €320,000, ‘NanoInteract’, for <strong>research</strong> into nanoparticlepreparation techniques for biological substrates, delivery systems and toxicity measurements at the cellular level.Two full-time RAs are involved in this work. The group has also learned that it has been successful in attracting EUFP7 funding €450,000, ‘NeuroNano’, which will start in the near future and allow the expansion <strong>of</strong> the nanotoxicolgyactivities.Tissue Development:A process that commences in the embryo but goes on throughout life and includes degenerative processes. Onemain area <strong>of</strong> interest is the vascularisation <strong>of</strong> tissues in health and disease states such as wound healing and oculardevelopment. During 2008 an EPSRC grant to investigate the role <strong>of</strong> angiogenesis in wound healing (£260,000 – UUcomponent)) came to an end (Joint between Nottingham, Brighton and UU) which examined the role <strong>of</strong> bloodvessel growth over time in the same wound and modelling their growth based on structural and physiologicalparameters. This led to several publications on the longitudinal analysis <strong>of</strong> wounds using epi-fluorescence and confocalmicroscopy, which is a particular strength <strong>of</strong> the group. We have also attracted a grant from the BBSRC (£356,000 –UU component) will commence in February 2008 in conjunction with colleagues at Heriot-Watt and the <strong>University</strong><strong>of</strong> Dundee. This collaborative project is examining the cellular and molecular determinants <strong>of</strong> retinal vascular plexusformation and how mathematical modelling can be used to predict the outcome <strong>of</strong> vascular patterning.. Anothermajor strand <strong>of</strong> interest concerns neurodegenerative conditions such as Alzheimer’s and Parkinson’s diseases, usinganimal models. The new FP7 grant will, when it comes on stream, allow for the integration <strong>of</strong> the neurodegenerativeand nanotoxicology strands <strong>of</strong> <strong>research</strong>. Tissue engineering techniques are being investigated with colleagues inBoston (USA) to develop an in vitro model <strong>of</strong> breast tissue to study the relationship between tissue dysgenesisand cancer. In all the tissue development projects the use <strong>of</strong> stereology, for which this group has an internationalreputation for innovation and excellence, is a common factor.Instrumentation:This year has seen the finalisation the Centre for Advanced Imaging centred around the 3 new FEI electronmicroscopes recently installed. This includes a unique cryo-dual beam SEM which facilitates ‘nano-milling’ <strong>of</strong> frozenbiological tissue with imaging able to resolve 2 nanometres. This will prove invaluable in nanotoxicology <strong>research</strong>.The group is <strong>research</strong>ing, in collaboration with Unilever <strong>Research</strong>, a Raman spectroscopy facility which will lead to‘chemical mapping’ at the nanoscale, which is going to be the next big development in bioimaging.Members <strong>of</strong> the Group:Academic Staff:Pr<strong>of</strong>essor Vyvyan HowardGroup Leader: Pr<strong>of</strong>essor <strong>of</strong> BioimagingContact Details:T: +44 (0)28 70323383v.howard@ulster.ac.ukDuring the year Vyvyan Howard was elected a Fellow <strong>of</strong> the Collegium Ramazzini, one <strong>of</strong> the foremost institutions20
addressing environment and health, at a ceremony in Carpi in Italy. Bernado Ramazzini (1633-1717) was the firstoccupational physician, linking environment degradation with health outcomes. Pr<strong>of</strong>essor Howard, a registeredmedical practitioner himself, was elected on the strength <strong>of</strong> his contribution to the field <strong>of</strong> environmental pollutionand ill-health.Pr<strong>of</strong>essor Howard has continued to serve <strong>of</strong> the UK Government DEFRA Advisory Committee on Pesticides.During this period he co-authored a paper with Pr<strong>of</strong>essor Luc Montagnier (Irigaray et al, 2007), who recentlyreceived the Nobel Prize for Medicine.Work has continued on the NanoInteract project, which has recently come out <strong>of</strong> its mid-term assessment withvery positive comments. The <strong>University</strong> <strong>of</strong> <strong>Ulster</strong>’s contribution to this work in the preparation, characterisation andintracellular fate <strong>of</strong> nanoparticle preparations is being widely recognised. Pr<strong>of</strong>essor Howard continues to develop theBioimaging <strong>Research</strong> Group into a widely recognised centre <strong>of</strong> international importance in the study <strong>of</strong> nanomaterialtoxicology.Preparative work is commencing on a study to investigate the impact <strong>of</strong> low dose endocrine disrupting pesticideexposure <strong>of</strong> the rat fetus during pregnancy. Structural changes to the architecture <strong>of</strong> tissues will be measured usingnovel stereological techniques, developed within the Bioimaging <strong>Research</strong> Group, which will lead to the detection<strong>of</strong> ‘minimal change pathology’ – being much more sensitive than the classical pathologist in the detection <strong>of</strong> change.Publications:Barnes CA, O’Hagan BMG, Howard CV, McKerr G; Verification <strong>of</strong> cell viability at progressively higher scanning forcesusing a hybrid atomic force and fluorescence microscope.” Journal <strong>of</strong> Microscopy, 228: 185-189, 2007Ellis KA, Innocent GT, Mihm M, Cripps P, McLean WG, Howard CV and Grove-White D; Dairy cow cleanliness andmilk quality on organic and conventional farms in the UK; Journal <strong>of</strong> Dairy Science, 89: 1938-1950, 2007Ellis KA, Monteiro A, Innocent GT, Grove-White D, Cripps P, McLean WG, Howard CV, Mihm M; Investigation<strong>of</strong> the vitamins A and E and beta-carotene content in milk from UK organic and conventional dairyfarms; Journal <strong>of</strong> Dairy <strong>Research</strong>, 74: 484-491, 2007Irigaray P, Newby JA, Clapp R, Hardell L, Howard CV, Montagnier L, Epstein S, Belpomme D; Lifestyle-related factorsand environmental agents causing cancer: An overview; Biomedicine & Pharmacotherapy, 61: 640-658, 2007Newby JA, Busby CC, Howard CV and Platt MJ; The cancer incidence temporality index: An index to show thetemporal changes in the age <strong>of</strong> onset <strong>of</strong> overall and specific cancer (England and Wales, 1971-1999); Biomedicine andPharmacotherapy, 61: 623-630, 2007Sneddon JC, Ritruechait P, Staats de Yanes G and Howard CV; Seasonal influences on quantitative changes in sweatassociatedanatomy in native and thoroughbred horses; Veterinary Dermatology, 19: 163-173, 2008Pr<strong>of</strong>essor Ana SotoPr<strong>of</strong>essor <strong>of</strong> Cancer DevelopmentContact Details:a.soto@ulster.ac.ukEndocrine disruptors:Pr<strong>of</strong>essor Soto and Pr<strong>of</strong>essor Howard were funded by the Organix Foundation (Pesticide exposure during fetal life,08-11). This <strong>research</strong> project will reveal whether commonly used pesticides, at current levels <strong>of</strong> exposure, cause21
- Page 1: BIOMEDICAL SCIENCESRESEARCH INSTITU
- Page 4 and 5: 1 Foreword by the Pro Vice-Chancell
- Page 6 and 7: 2 Foreword by the Research Institut
- Page 8 and 9: The BMSRI Research StructureThe BMS
- Page 10 and 11: BMSRI Core FacilitiesContact: Karen
- Page 12 and 13: of Metabolomics, pharmacy, nutritio
- Page 14 and 15: BMSRI Academic Heads new Regional N
- Page 16 and 17: 4. BIOMEDICAL GENOMICS RESEARCH GRO
- Page 18 and 19: Recent Funding Initiatives:C-TRIC:
- Page 20 and 21: Dr Mateus Webba da SilvaLecturer in
- Page 24 and 25: developmental alterations that mani
- Page 26 and 27: Publications:Bigot S, Lucas L, Morr
- Page 28 and 29: Publications:Barnes CA, O’Hagan B
- Page 30 and 31: We also measure the genotoxic effec
- Page 32 and 33: 6. CANCER AND AGEING RESEARCH GROUP
- Page 34 and 35: Professor Anthony P McHaleProfessor
- Page 36 and 37: Professor Stephanie McKeownProfesso
- Page 38 and 39: an Alzheimer Research Trust collabo
- Page 40 and 41: JM, Waugh DJJ; Dexamethasone potent
- Page 42 and 43: have wider applications in vivo, in
- Page 44 and 45: Inter-relationships between diet an
- Page 46 and 47: Flatt PR; Effective surgical treatm
- Page 48 and 49: These areas are the subject of seve
- Page 50 and 51: Dr YHA Abdel-WahabSenior Lecturer i
- Page 52 and 53: Dr VA GaultLecturer in Molecular Bi
- Page 54 and 55: McClean PL, Irwin N, Hunter K, Gaul
- Page 56 and 57: Publications:Duffy NA, Green BD, Ir
- Page 58 and 59: 8. MICROBIOLOGY AND BIOTECHNOLOGYRE
- Page 60 and 61: Publications:Graham RJL, Graham C,
- Page 62 and 63: analyses. However there is still a
- Page 64 and 65: Plessas S, Bekatorou A, Koutinas AA
- Page 66 and 67: Biochemical studies/ viral evasion
- Page 68 and 69: Dr Stephen McCleanLecturer in Prote
- Page 70 and 71: environmental remediation and as ro
- Page 72 and 73:
9. NORTHERN IRELAND CENTRE FOR FOOD
- Page 74 and 75:
26-28 Sept 2007: International Seaf
- Page 76 and 77:
Dr Barnes has developed expertise i
- Page 78 and 79:
Dr Alison GallagherSenior Lecturer
- Page 80 and 81:
In addition, results of a pilot stu
- Page 82 and 83:
Dr Maeve KerrResearch AssociateCont
- Page 84 and 85:
Memberships of External Committees/
- Page 86 and 87:
Indicators of Esteem:Professor McNu
- Page 88 and 89:
were examined. The intervention and
- Page 90 and 91:
Within this work both short-term an
- Page 92 and 93:
micronutrient supplementation at a
- Page 94 and 95:
10. STEM CELL & EPIGENETICS RESEARC
- Page 96 and 97:
Publications:Lees-Murdock DJ, Lau H
- Page 98 and 99:
Publications:Lees-Murdock DJ, Lau H
- Page 100 and 101:
11. SYSTEMS BIOLOGY RESEARCH GROUPT
- Page 102 and 103:
Kravtsov V, Swain M, Schuster A, Du
- Page 104 and 105:
Dr Daniel BerrarLecturer in Biomedi
- Page 106 and 107:
Zhang et al; Incorporating Feature
- Page 108 and 109:
Bala P, Baldridge K, Benfenati E, C
- Page 110 and 111:
In addition there is a growing them
- Page 112 and 113:
Clinical work involves development
- Page 114 and 115:
In 2009 he was appointed Chairman o
- Page 116 and 117:
Stevenson TR, Goodall EA and Moore
- Page 118 and 119:
Dr Raymond BeirneLecturer in Optome
- Page 120 and 121:
Dr Julie McClellandLecturer in Opto
- Page 122 and 123:
Graham JE, Moore JE, Moore JE, McCl
- Page 124 and 125:
Research Staff:Dr David OrrSenior R
- Page 126 and 127:
Dr Victoria McGilliganResearch Asso
- Page 128 and 129:
13. Externally Funded Projects duri
- Page 130 and 131:
Grant Holder Anderson, Prof RSFundi
- Page 132 and 133:
Funding Body Royal Irish AcademyAmo
- Page 134 and 135:
14. BIOMEDICAL SCIENCES RESEARCH IN
- Page 136 and 137:
Student: Simon GenglerTitle: Effect
- Page 138 and 139:
Student: Anisha MazumdarTitle: Anal
- Page 140 and 141:
Student: Clare RyanTitle: How does
- Page 142 and 143:
CONGRATULATIONS TO THE FOLLOWING PO